At Sensus Healthcare, we are committed to advancing patient care and empowering dermatology practices with innovative solutions. One of our most exciting developments in 2024 is the launch of the Fair Deal Agreement, a program designed to bring unprecedented value, efficiency, and growth opportunities to dermatology practices offering Superficial Radiation Therapy (SRT).
What is the Fair Deal Agreement?
The Fair Deal Agreement is a recurring revenue program tailored to address the evolving needs of dermatology practices. This program provides practices with a non-invasive, highly effective treatment option for non-melanoma skin cancer using the SRT-100 Vision—while optimizing economic outcomes for the practice.
Here’s how it works:
- Revenue Alignment: The Fair Deal Agreement links revenue generation directly to patient treatment volume. The more patients treated with the SRT-100 Vision, the more revenue the practice generates.
- Capital Preservation: By alleviating the need for significant upfront capital investment, practices can allocate resources to other critical areas of growth.
Advancing Technology with the SRT-100 Vision
Central to the success of the Fair Deal Agreement is the cutting-edge SRT-100 Vision system. Featuring state-of-the-art technology, including newly patented capabilities, this device is a game-changer in dermatological care.
The system integrates high-frequency ultrasound with radiation therapy, enabling precise treatment planning and seamless operation under the Fair Deal Agreement program. With 33 individual claims covered by this technology, practices benefit from a streamlined, efficient process that enhances patient outcomes and practice revenue alike.
Why the Fair Deal Agreement Matters
For Dermatology Practices:
- Ease of Adoption: Practices can offer advanced skin cancer treatments without the burden of upfront capital costs.
- Revenue Growth: Practices gain a predictable, scalable revenue model tied directly to patient volume.
- Operational Support: CureRays ensures optimal efficiency, allowing practices to focus on delivering exceptional care.
For Patients:
- Access to Advanced Care: The SRT-100 Vision offers a non-invasive alternative to surgery for non-melanoma skin cancer.
- Improved Outcomes: Precision treatment planning ensures efficacy and patient comfort.
The Future of Dermatology with Sensus Healthcare
As customer interest in the Fair Deal Agreement continues to grow daily, Sensus Healthcare is proud to lead the way in transforming how dermatology practices operate. This program represents a win-win for providers and patients, reinforcing our mission to deliver innovative solutions that benefit the entire dermatological community.
Ready to explore the Fair Deal Agreement and the state-of-the-art SRT-100 Vision? Learn more about how Sensus Healthcare can elevate your practice.
